Clinical Trials Logo

Clinical Trial Summary

To measure the levels of endothelial progenitor cells and CD34+ hematopoietic stem cells levels, and placental residual volume by delayed cord clamping, umbilical cord milking or immediate cord clamping in newborns at different gestational weeks.


Clinical Trial Description

Umbilical cord blood is a rich source of stem cells. Placental transfusion is the transfer of the placental blood to the baby until the cord clamped during the birth. Placental transfusion can be accomplished by delayed cord clamping or umbilical cord milking.

One group will receive 2 minutes of delayed cord clamping, the second group will receive umbilical cord milking and the third group will receive immediate cord clamping. Following the cord clamping, the blood samples will be taken from the placental site of the umbilical cord to measure the stem cells from all subjects and placental residual volume will be measured.

Delivery room conditions, hospitalization (if needed), short-term outcome during hospitalization, prematurity related morbidities (if baby is preterm) will be recorded. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03983902
Study type Interventional
Source Ankara University
Contact Emel Okulu, MD
Phone +90-312-595000
Email emelokulu@gmail.com
Status Not yet recruiting
Phase N/A
Start date July 1, 2019
Completion date June 30, 2021

See also
  Status Clinical Trial Phase
Withdrawn NCT03629015 - Safety Study of Stemchymal® in Acute Liver Failure Phase 1
Not yet recruiting NCT04998461 - Impact of Obesity, Chronic Kidney Disease and Type 2 Diabetes on Human Urinary Stem Cells
Completed NCT04132531 - Effect of Weight Loss Surgery on Stem Cells.
Completed NCT03381599 - Stem Cells After Peripheral Mobilization and Harvest Phase 1
Completed NCT02697682 - Treatment of Osteoarthritis With the Stromal Vascular Fraction of Abdominal Adipose Tissue - a Pilot Study N/A
Active, not recruiting NCT03874572 - Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth Phase 1
Not yet recruiting NCT03361631 - Intracavernous Injection of Autologous Mesenchymal Stem Cells in the Treatment of Erectile Dysfunction Resistant to Oral Treatment in Patients With Type I Diabetes Phase 1
Completed NCT06219161 - The Acute Effect of a Theacrine-based Supplement on Mobilization of Various Stem Cell Populations. N/A
Completed NCT04713436 - The Effects of Antibiotic Combinations on Stem Cells
Active, not recruiting NCT03028428 - Intra-articular Injection of MSCs in Treatment of Knee OA Phase 2
Recruiting NCT04646603 - MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients Phase 2
Withdrawn NCT02677350 - AlloGeneic Human Mesenchymal Stem Cells (hMSC) in PAtients With FistuLizing Crohn's Disease Via PErifistula iNjEctions (GALENE) Phase 1
Completed NCT00340392 - Isolation and Characterization of Mammary Stem Cells N/A
Terminated NCT00316069 - Stem Cell Collection